semaglutide alcohol use disorder study Could GLP-1 medications help transform treatment for addiction? Alcohol affects millions, yet there haven't been any new medications approved to treat it in 20 years. Now, new #CUAnschutz research GLP-1s are changing US healthcare,

Unfortunately, oxidative stress may be what causes you to develop migraine disease because the buildup of ROS tips the balance of inflammatory and anti-inflammatory processes in favor of inflammation, triggering inflammatory cascades that lead to migraine attacks

Additional information

Ferraldeschi, R

The randomised, double-blind, placebo-controlled trial was conducted across 12 countries and enrolled 1206 adults with Type 2 diabetes, a body mass index (BMI) of at least 27, and HbA1c between 7% and 10%

Centers for Medicare & Medicaid Services (2026) Medicaid coverage of and spending on GLP-1s, KFF (2026) Tirzepatide as compared with semaglutide for the treatment of obesity, The New England Journal of Medicine (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice